Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MLND

Millendo Therapeutics (MLND) Stock Price, News & Analysis

Millendo Therapeutics logo

About Millendo Therapeutics Stock (NASDAQ:MLND)

Advanced Chart

Key Stats

Today's Range
$6.11
$6.38
50-Day Range
$3.06
$5.84
52-Week Range
$0.92
$16.95
Volume
19,846 shs
Average Volume
1.52 million shs
Market Capitalization
$118.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

As of June 25, 2021, Millendo Therapeutics, Inc. was acquired by Tempest Therapeutics Inc., in a reverse merger transaction. Millendo Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Ann Arbor, Michigan.

Receive MLND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Millendo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

MLND Stock News Headlines

Memorial Day Sale! 82% Off Disruptors and Dominators!
Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidia CEO walked on stage, you could've heard a pin drop. Why? Robots — built by Nvidia.
Maxim Group Maintains Their Buy Rating on Mind Medicine (MMED)
Expert Ratings for Decibel Therapeutics
See More Headlines

MLND Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Millendo Therapeutics investors own include Elbit Systems (ESLT), UnitedHealth Group (UNH), AbbVie (ABBV), American Water Works (AWK), Bright Health Group (BHG), Black Hills (BKH) and Blackrock Municipal 2030 Target Term Trust (BTT).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MLND
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-36,410,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.78 per share
Price / Book
3.50

Miscellaneous

Free Float
N/A
Market Cap
$118.64 million
Optionable
Not Optionable
Beta
0.48
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:MLND) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners